Innovent Biologics Statistics

Total Valuation

HKG:1801 has a market cap or net worth of HKD 96.66 billion. The enterprise value is 91.29 billion.

Market Cap	96.66B
Enterprise Value	91.29B

Important Dates

The next estimated earnings date is Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:1801 has 1.65 billion shares outstanding. The number of shares has increased by 4.35% in one year.

Current Share Class	1.65B
Shares Outstanding	1.65B
Shares Change (YoY)	+4.35%
Shares Change (QoQ)	+0.57%
Owned by Insiders (%)	6.73%
Owned by Institutions (%)	41.38%
Float	1.53B

Valuation Ratios

PE Ratio	n/a
Forward PE	217.95
PS Ratio	9.64
PB Ratio	6.92
P/TBV Ratio	7.09
P/FCF Ratio	282.65
P/OCF Ratio	70.58
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-906.48
EV / Sales	9.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	266.93

Financial Position

The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.22.

Current Ratio	2.35
Quick Ratio	2.08
Debt / Equity	0.22
Debt / EBITDA	50.93
Debt / FCF	8.81
Interest Coverage	-4.09

Financial Efficiency

Return on equity (ROE) is -0.74% and return on invested capital (ROIC) is -1.08%.

Return on Equity (ROE)	-0.74%
Return on Assets (ROA)	-0.82%
Return on Invested Capital (ROIC)	-1.08%
Return on Capital Employed (ROCE)	-1.60%
Revenue Per Employee	1.77M
Profits Per Employee	-17,795
Employee Count	5,659
Asset Turnover	0.45
Inventory Turnover	2.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +54.21% in the last 52 weeks. The beta is 0.28, so HKG:1801's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	+54.21%
50-Day Moving Average	47.88
200-Day Moving Average	41.54
Relative Strength Index (RSI)	70.41
Average Volume (20 Days)	22,441,934

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1801 had revenue of HKD 10.03 billion and -100.70 million in losses. Loss per share was -0.06.

Revenue	10.03B
Gross Profit	7.46B
Operating Income	-294.32M
Pretax Income	-83.67M
Net Income	-100.70M
EBITDA	25.53M
EBIT	-294.32M
Loss Per Share	-0.06

Full Income Statement

Balance Sheet

The company has 8.39 billion in cash and 3.01 billion in debt, giving a net cash position of 5.38 billion or 3.26 per share.

Cash & Cash Equivalents	8.39B
Total Debt	3.01B
Net Cash	5.38B
Net Cash Per Share	3.26
Equity (Book Value)	13.96B
Book Value Per Share	8.52
Working Capital	6.28B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.37 billion and capital expenditures -1.03 billion, giving a free cash flow of 341.98 million.

Operating Cash Flow	1.37B
Capital Expenditures	-1.03B
Free Cash Flow	341.98M
FCF Per Share	0.21

Full Cash Flow Statement

Margins

Gross margin is 74.40%, with operating and profit margins of -2.94% and -1.00%.

Gross Margin	74.40%
Operating Margin	-2.94%
Pretax Margin	-0.83%
Profit Margin	-1.00%
EBITDA Margin	0.25%
EBIT Margin	-2.94%
FCF Margin	3.41%

Dividends & Yields

HKG:1801 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.35%
Shareholder Yield	n/a
Earnings Yield	-0.10%
FCF Yield	0.35%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1801 has an Altman Z-Score of 3.86.

Altman Z-Score	3.86
Piotroski F-Score	n/a